Journal Home
Search for

Volume 36, Issue 3, Pages 237-243 (March 2010)


View previous. 5 of 21 View next.

Clinical outcome in 520 consecutive Danish rectal cancer patients treated with short course preoperative radiotherapy

L.H. JensenaCorresponding Author Informationemail address, R. Altafb, H. Harlingc, M. Jensend, S. Laurberge, J.C. Lindegaardf, A. Muhicg, L. Vestermarkh, A. Jakobsena, S. Bülowi, on behalf of the Danish Colorectal Cancer Group

Accepted 8 October 2009.

Abstract 

Aim

The purpose of this study was to analyse the results of preoperative short course radiotherapy in a consecutive, national cohort of patients with rectal cancer.

Methods

Through a validated, prospective national database we identified 520 Danish patients who presented with high-risk mobile tumours in the lower two thirds of the rectum and were referred for preoperative radiotherapy with 5 × 5 Gy. The inclusion period was 56 months. Radiotherapy data was retrospectively collected.

Results

Of the 520 patients, 514 completed radiotherapy and 506 had surgery. Surgery was considered curative in 439 patients. The 3-year local recurrence rate was 4.0% (95% CI 2.5–6.5%) and the distant recurrence rate at 3 years was 18.7% (95% CI 15.4–22.5%). The 5-year disease free survival rate was 40.2% (95% CI 27.0–53.1%) and overall survival 50.4% (95% CI 36.1–63.1%). Most tumours (61%) were classified as T3 or T4 and 41% of the local recurrences occurred in patients with a fixed tumour at surgery.

Conclusion

This study confirms data from randomised studies that the short course 5 × 5 Gy regime is a feasible treatment for locally advanced rectal cancer even when applied in a population outside clinical trials.

a Department of Oncology, Vejle Hospital, Kabbeltoft 25, DK 7100 Vejle, Denmark

b Department of Oncology, Herlev Hospital, Copenhagen, Denmark

c Department of Surgery, Bispebjerg Hospital, Copenhagen, Denmark

d Department of Oncology, Aalborg Hospital, Aalborg, Denmark

e Department of Surgery, Aarhus Hospital, Aarhus, Denmark

f Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

g Department of Oncology, Rigshospitalet, Copenhagen, Denmark

h Department of Oncology, Odense Hospital, Odense, Denmark

i Department of Surgery, Hvidovre Hospital, Copenhagen, Denmark

Corresponding Author InformationCorresponding author. Tel.: +45 7940 5000; fax: +45 7940 6710.

PII: S0748-7983(09)00480-6

doi:10.1016/j.ejso.2009.10.008


View previous. 5 of 21 View next.